Oracle (ORCL) announced new updates to Oracle Life Sciences Empirica Signal and Topics. The latest release of Oracle’s market-leading signal detection and management solution extends out-of-the-box database choices for global safety monitoring and enhances the signal review process with versioned case-level annotation that enables users to drill into single-case assessments. Oracle continues to advance precision pharmacovigilance through cloud-based technologies, AI, and an expanding suite of real-world data capabilities.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- SoundHound (SOUN) Experiences Explosive Growth by Harnessing Voice-Based AI
- S&P 500 Slides Lower After October’s Inflation Data
- Amazon vs. Alphabet: Which Cloud Hyperscaler Offers Greater Value?
- AMD and IBM Stocks Climb on AI Partnership to Boost Performance
- Oracle price target raised to $200 from $190 at KeyBanc